29,147 Followers on Owler
OverviewCompetitorsAcquisitionsFundingInvestmentsNews & Insights

GSK Acquisitions

GSK has acquired 17 companies and its latest acquisition was IDRx, Inc. on Jan 2025

Unlock 14 more acquisitions →
COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION
IDRx, Inc.

Jan 2025

Source »
$1B
IDRx is a Massachusetts-based clinical-stage biopharmaceutical company that researches and develops precision therapies for the treatment of cancer.
Elsie Biotechnologies

Jun 2024

Source »
$50M
Elsie Biotechnologies is a California-based biopharmaceutical company that researches and develops homogeneous oligonucleotide therapeutics to treat human diseases.
Aiolos Bio, Inc.

Jan 2024

Source »
$1.4B
Aiolos Bio is a Massachusetts-based clinical-stage biopharmaceutical company that researches and develops novel therapeutics for respiratory and inflammatory diseases.
BELLUS Health, Inc.

Apr 2023

Source »
$2B
BELLUS is a Canada-based biopharmaceutical company that develops and commercializes novel therapeutics for the treatment of refractory chronic cough disorders.
Affinivax, Inc.

May 2022

Source »
$3.3B
Affinivax is a Massachusetts-based biopharmaceutical company that develops and commercializes novel vaccines for the treatment of infectious diseases.

Frequently Asked Questions about GSK

  1. What companies did GSK acquire?

    Companies acquired by GSK include IDRx, Elsie Biotechnologies and Aiolos Bio

  2. How many acquisitions does GSK have?

    GSK has acquired 17 companies including IDRx, Elsie Biotechnologies and Aiolos Bio.

  1. How many acquisitions did GSK make in 2025?

    In 2025 GSK acquired 1 companies including IDRx.